ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 390 filers reported holding ASTRAZENECA PLC in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $372,000 | -23.0% | 13,629 | -7.2% | 0.01% | -29.4% |
| Q3 2016 | $483,000 | +7.6% | 14,694 | -1.2% | 0.02% | +6.2% |
| Q2 2016 | $449,000 | -27.1% | 14,871 | -32.0% | 0.02% | -38.5% |
| Q1 2016 | $616,000 | +38.1% | 21,884 | +66.4% | 0.03% | +30.0% |
| Q4 2015 | $446,000 | +120.8% | 13,148 | +107.3% | 0.02% | +25.0% |
| Q3 2015 | $202,000 | +106.1% | 6,344 | +310.9% | 0.02% | +128.6% |
| Q2 2015 | $98,000 | +14.0% | 1,544 | +22.4% | 0.01% | +16.7% |
| Q1 2015 | $86,000 | 0.0% | 1,261 | +3.4% | 0.01% | -33.3% |
| Q4 2014 | $86,000 | +62.3% | 1,219 | +65.6% | 0.01% | +50.0% |
| Q3 2014 | $53,000 | -5.4% | 736 | -2.0% | 0.01% | -14.3% |
| Q2 2014 | $56,000 | -56.2% | 751 | -62.2% | 0.01% | -22.2% |
| Q1 2014 | $128,000 | +26.7% | 1,986 | +16.7% | 0.01% | -40.0% |
| Q4 2013 | $101,000 | +13.5% | 1,702 | -0.5% | 0.02% | -6.2% |
| Q3 2013 | $89,000 | +34.8% | 1,710 | +22.7% | 0.02% | +23.1% |
| Q2 2013 | $66,000 | – | 1,394 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |